Metabotropic Glutamate Receptor Genes as Candidates for Pharmacogenetic Studies of Current and Future Antipsychotic Agents in Schizophrenia

Publisher： Bentham Science Publishers

E-ISSN： 1875-6204|5|1|21-30

ISSN： 1570-1603

Source： Current Pharmacogenomics, Vol.5, Iss.1, 2007-03, pp. : 21-30

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Metabotropic Glutamate Receptor Genes in Schizophrenia

By  

Current Neuropharmacology, Vol. 14, Iss. 5, 2016-06 ,pp. : 540-550

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Potential Therapeutics for Schizophrenia: Focus on the Modulation of Metabotropic Glutamate Receptor Function

By  

Current Neuropharmacology, Vol. 3, Iss. 1, 2005-01 ,pp. : 9-34

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Developments of the PET Imaging Agents for Metabotropic Glutamate Receptor Subtype 5

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 18, 2007-09 ,pp. : 1800-1805

Bentham Science Publishers

Access to resources Recommend Favorite

Metabotropic Glutamate Receptors as Targets for Novel Antipsychotic Treatments

By  

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 8, 2012-06 ,pp. : 1522-1534

Bentham Science Publishers

Access to resources Recommend Favorite

Different effects of NMDA/group I metabotropic glutamate receptor agents in - and -opioid receptor agonist-induced supraspinal antinociception

By Suzuki T.   Aoki T.   Ohnishi O.   Nagase H.   Narita M.  

European Journal of Pharmacology, Vol. 396, Iss. 1, 2000-05 ,pp. : 23-28

Elsevier

Access to resources Recommend Favorite